title: Medical and surgical treatment of neovascular glaucoma.
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Olmos
authors.forename: Richard K
authors.initials: RK
authors.lastname: Lee
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000068258:Bevacizumab; D020327:Glaucoma Drainage Implants / Q000009:adverse effects; D015355:Glaucoma, Neovascular / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D058449:Intravitreal Injections; D007511:Ischemia / Q000150:complications / Q000601:surgery; D008028:Light Coagulation; D012171:Retinal Vessels / Q000601:surgery; D014130:Trabeculectomy
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000959:Antihypertensive Agents; D000068258:Bevacizumab